Companies /Healthcare

Abbvie Inc

NYSE: ABBV Drug Manufacturers - General
$285.42
▲ $2.02 (+0.71%) today
Markets closed · 10:53am ET

ABBV Coverage Page 43

10:45am ET
Investing

The 7 Most Heavily Shorted NYSE Stocks

Only one of the seven stocks traded on the New York Stock Exchange with the largest number of shares held short as of October 15 experienced a decline in short interest.

Paul Ausick
8:40am ET
Health and Healthcare

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie reported better-than-expected second-quarter 2014 results before markets opened Friday morning, due in part to strong sales of its Humira anti-inflammatory drug.

Paul Ausick